NAS10027,087+1.72%S&P7,401+0.65%GOLD$4,073−1.00%BTC$75,828−0.15%VIX24.55−12.88%latest tape · as of 20:03 UTC
The Screen · Consumer Cyclical · Specialty Retail
CHPTChargePoint Holdings Inc
CHPT · the NYSE · USD · Market cap $137M · 1,440 employees
ChargePoint Holdings, Inc., together with its subsidiaries, provides electric vehicle (EV) charging technology solutions in the United States and internationally.
FAIL · Does not pass the screen
10.96 USD
Price as of 5 Nov 2026Daily close, not a live quote
Screened 2026-11-05 · the tape above runs as of 20:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price10.96 USD at the 5 Nov 2026 close
Our value readOvervalued vs our fair value, as of 5 Nov 2026
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.51, read 2026-11-03
Ethical does not pass the values gate
Price10.96 USD
Fair value6.50
Ethical score70.0/100
Value readOvervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-10-11Read Distribution9.41+16.5% to today Markup gives way to Distribution with volume flow in agreement
2026-10-02Read Markup9.41+16.5% to today ✓Accumulation gives way to Markup after a 32% rise in 13 weeks
2026-07-02Read Accumulation7.14+53.5% to today ✓First review on file: Accumulation
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
ChargePoint Holdings Inc holds its Markup at $10.96. Elevated stress, defensive posture warranted, held for 20 days.
As held on the ledger · 2026-11-05
Phase
Markup
Quantitative state
Elevated stress, defensive posture warranted, held for 20 days
Price at the screen
$10.96
Valuation
N/A trailing · -2.78 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.72
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
34.27%
Below 33%
Interest-bearing debt is 34.3% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
28.74%
Below 49%
Money owed to the company is 28.7% of assets, under the 49% limit.
Pass
Revenue purity
1.09%
Below 5%
Only 1.1% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
ChargePoint's business is in a permissible area, but its interest-bearing debt is about 34% of the company, just over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when CHPT's ethical verdict changes
Today CHPT does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Overvalued vs our fair value, as of 5 Nov 2026: it trades above our $6.50 fair value estimate, none competitive moat, 4.30% revenue growth.
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. The price runs 68.6% above the base estimate.
Where our models see it going: fair-value estimate $6.50, with a range of $5.70 to $8.00, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Why it gives us pause
At -2.8x forward earnings, the price already runs ahead of the business. It trades 75% above our $6.50 fair value, so you would be buying at a premium, not a discount. The none moat is real, but quality alone does not make an expensive price cheap.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
CHPT trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-01Distribution$9.54+32.0%Entry 10
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 32.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are down 59%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (6 analysts) rates it hold, with a mean price target of $6.
2026-10-25Distribution$7.23+0.0%Entry 9
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading bearish. Over the past year the shares are down 59%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (6 analysts) rates it hold, with a mean price target of $6.
2026-10-18Distribution$7.23-23.2%Entry 8
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 23.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 59%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (6 analysts) rates it hold, with a mean price target of $6.
2026-10-11Distribution · changed$9.41+0.0%Entry 7
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 59%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (6 analysts) rates it hold, with a mean price target of $6.
2026-10-02Markup · changed$9.41+67.1%Entry 6
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 67.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 59%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (6 analysts) rates it hold, with a mean price target of $6. Since the last review it its composite score eased.
2026-08-25Accumulation$5.63+0.0%Entry 5
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 59%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (6 analysts) rates it hold, with a mean price target of $6.
2026-07-24Accumulation$5.63-21.1%Entry 4
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 21.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 59%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (6 analysts) rates it hold, with a mean price target of $6.
2026-07-18Accumulation$7.14+0.0%Entry 3
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 59%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (6 analysts) rates it hold, with a mean price target of $6.
2026-07-03Accumulation$7.14+0.0%Entry 2
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
2026-07-02Accumulation$7.14Entry 1
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.